Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

Hemogenomics provides blood transfusion, screening and diagnostics services. Read more

122 Followers on Owler
122 Followers on Owler
122 Followers on Owler
122 Followers on Owler

Hemogenomics provides blood transfusion, screening and diagnostics services. Read more

Sumit Bagaria's photo - CEO of Hemogenomics

CEO

Sumit Bagaria

CEO Approval Rating

89/100

Founded:

2001

Status:

PrivateIndependent Company

SIC Code:

8000 NAICS listing »

Est. Annual Revenue
Est. Employees
Sector

Update Industry
Headquarters

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

The top 10 competitors in Hemogenomics' competitive set are Transasia Bio-Medicals Ltd., Trivitron, Roche, SPAN Healthcare Pvt. Ltd., Horizon Medical Services Ltd., Lilac Medicare, Merck, Novartis, BMS, Johnson & Johnson, Pfizer, GSK, Medtronic, Accurex Biomedical Pvt. Ltd., Tulip Diagnostics, Bio Lab Diagnostics, Biosense Technologies, Eli Lilly, Abbott, Amgen, GE Healthcare, AstraZeneca, Gilead, Raj Biosis and Cipla Ltd.. Together they have raised over 11.4B between their estimated 1.0M employees. Hemogenomics's revenue is the ranked 19th among it's top 10 competitors. The top 10 competitors average 19.5B. Hemogenomics has 100 employees and is ranked 22th among it's top 10 competitors. The top 10 competitors average 37,658.

Transasia Bio-Medicals Ltd. is one of Hemogenomics's top competitors. Transasia Bio-Medicals Ltd. is a Private company that was founded in Mumbai, Maharashtra in 1979. Transasia Bio-Medicals Ltd. is in the Health Care Services field. Transasia Bio-Medicals Ltd. has 2,700 more employees vs. Hemogenomics.

Trivitron is perceived as one of Hemogenomics's biggest rivals. Trivitron was founded in 1997 in Chennai, Tamil Nadu. Trivitron operates in the Health Care Equipment industry. Trivitron generates $19.4M more revenue than Hemogenomics.

Roche is a top competitor of Hemogenomics. Roche's headquarters is in Basel, Basel-Country, and was founded in 1896. Roche competes in the Biotechnology field. Roche generates 633,238% of Hemogenomics's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $10M a good estimate for Hemogenomics's revenue?

I don't know

Trending News for Hemogenomics and Hemogenomics's Competitors

January 25, 2021

CompanyNews HQ

Roche's faricimab meets primary endpoint in two global phase III studies and shows potential to extend time between treatments up to 16 weeks for people with neovascular age-related macular degeneration

Faricimab given at intervals of up to every 16 weeks demonstrated non-inferior visual acuity gains co... See more »

January 25, 2021

The Business Journals: Philadelphia

Merck discontinues work on Covid-19 vaccine candidates

The company is continuing work on two therapeutics to treat coronavirus infections.... See more »

January 25, 2021

PMLiVE

BMS gains FDA approval for second Opdivo combo in kidney cancer

BMS' Opdivo/Yervoy regimen was its first combo to be approved for advanced renal cell carcinoma... See more »

Acquisitions

No recent acquisitions found related to Hemogenomics

Hemogenomics Funding History

No recent funding data found related to Hemogenomics

Investments

No recent investments found related to Hemogenomics

Hemogenomics News

October 27, 2015PHOENIX BUSINESS JOURNAL

Phoenix cancer diagnostics firm expects to garner $50M with India expansion

Global Cancer Diagnostics Inc. has signed a deal to distribute its early stage lung cancer test in In... See more »

Hemogenomics Press Releases

Social Media

Headquarters

Opp Indian Oil Petrol Bunk New BEL Road, Near M S Ramaiah Hospital 3rd Floor, Site No:26

Inn Bangalore, Karnataka560054

080-4215-1017

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Hemogenomics provides blood transfusion, screening and diagnostics services. Hemogenomics was founded in 2001. Hemogenomics' headquarters is located in Inn Bangalore, Karnataka, IN 560054. Hemogenomics' CEO, Sumit Bagaria, currently has an approval r...

CEO

Hemogenomics's CEO, Sumit Bagaria, currently has an approval rating of 89%. Hemogenomics's primary competitors are Transasia Bio-Medicals Ltd., Trivitron & Roche.

Website

hemogenomics.com

Frequently Asked Questions about Hemogenomics

  1. When was Hemogenomics founded?

    Hemogenomics was founded in 2001

  2. Who is Hemogenomics's CEO?

    Hemogenomics's CEO is Sumit Bagaria

  3. How much revenue does Hemogenomics generate?

    Hemogenomics generates $10M in revenue

  4. How much funding does Hemogenomics have?

    Hemogenomics has historically raised $0 in funding

  1. Where is Hemogenomics's headquarters?

    Hemogenomics's headquarters is in Inn Bangalore Karnataka, IN

  2. How many employees does Hemogenomics have?

    Hemogenomics has 100 employees

  3. Who are Hemogenomics's competitors?

    Hemogenomics's top competitors are Transasia Bio-Medicals Ltd., Trivitron, Roche
Stay up-to-date with the latest news on Hemogenomics

© 2021 Owler, Inc.